Upper tract transitional cell carcinoma: finding a way forward. Clark PE (2007) Cancer 110: 1648-9 Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG (2005) Cancer 103: 546-52 Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE (2009) Cancer 115: 770-5 Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG (2005) Cancer 104: 36-43 Bladder cancer. Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG, National Comprehensive Cancer Network (2009) J Natl Compr Canc Netw 7: 8-39 Myxoid cystitis with "chordoid" lymphocytes: another mimic of invasive urothelial carcinoma. Hameed O (2010) Am J Surg Pathol 34: 1061-5 DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. El-Rifai W, Kamel D, Larramendy ML, Shoman S, Gad Y, Baithun S, El-Awady M, Eissa S, Khaled H, Soloneski S, Sheaff M, Knuutila S (2000) Am J Pathol 156: 871-8 Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer. Reddy OL, Cates JM, Gellert LL, Crist HS, Yang Z, Yamashita H, Taylor JA, Smith JA, Chang SS, Cookson MS, You C, Barocas DA, Grabowska MM, Ye F, Wu XR, Yi Y, Matusik RJ, Kaestner KH, Clark PE, DeGraff DJ (2015) Am J Pathol 185: 1385-95 Bladder cancer. Borden LS, Clark PE, Hall MC (2003) Curr Opin Oncol 15: 227-33 Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Keegan KA, Resnick MJ, Clark PE (2012) Curr Opin Oncol 24: 278-83 Bladder cancer. Gwynn ES, Clark PE (2006) Curr Opin Oncol 18: 277-83 Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) J Urol 182: 2182-7 Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS (2009) J Urol 181: 540-5; discussion 546 The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. Clark PE, Stein JP, Groshen SG, Miranda G, Cai J, Lieskovsky G, Skinner DG (2004) J Urol 172: 1342-7 13-year experience with percutaneous management of upper tract transitional cell carcinoma. Clark PE, Streem SB, Geisinger MA (1999) J Urol 161: 772-5; discussion 775-6 Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, Groshen S, Lieskovsky G, Skinner DG (2007) J Urol 177: 876-81; discussion 881-2 Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG (2009) J Urol 181: 2052-8; discussion 2058-9 Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF (2008) J Urol 180: 520-4; discussion 524 Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort. Aghazadeh MA, Barocas DA, Salem S, Clark PE, Cookson MS, Davis R, Gregg J, Stimson CJ, Smith JA, Chang SS (2011) J Urol 185: 85-9 Volume outcomes of cystectomy--is it the surgeon or the setting? Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF (2012) J Urol 188: 2139-44 Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson CJ, Aghazadeh M, Smith JA, Barocas DA (2011) J Urol 185: 90-6 Tumor enzymes and prognosis in transitional cell carcinoma of the bladder: prediction of risk of progression in patients with superficial disease. Deshpande N, Mitchell IP, Hayward SW, Love S, Towler JM (1991) J Urol 146: 1247-51 Enzyme studies in human transitional cell carcinoma of the urinary bladder. Mitchell I, Hayward S, Deshpande N, Towler JM (1989) J Urol 141: 1234-7 Is bladder biopsy necessary at three or six months post BCG therapy? Highshaw RA, Tanaka ST, Evans CP, deVere White RW (2003) Urol Oncol 21: 207-9 Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device. Thompson IM, Kappa SF, Morgan TM, Barocas DA, Bischoff CJ, Keegan KA, Stratton KL, Clark PE, Resnick MJ, Smith JA, Cookson MS, Chang SS (2014) Urol Oncol 32: 45.e11-5 Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI (2015) Urol Oncol 33: 386.e1-6 Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer. Arnold SA, Loomans HA, Ketova T, Andl CD, Clark PE, Zijlstra A (2016) Clin Exp Metastasis 33: 29-44 Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, Cookson MS, Penson DF, Davis R, Clark PE, Smith JA, Chang SS (2014) BJU Int 113: 894-9 Invasive T1 bladder cancer: indications and rationale for radical cystectomy. Stein JP, Penson DF (2008) BJU Int 102: 270-5 Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, Smith JA, Cookson MS (2012) Urology 80: 632-40 Surgery for invasive bladder tumors: technique and outcome. Clark PE, Klein EA (1999) Curr Opin Urol 9: 413-8 Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer. Lin-Tsai O, Taylor JA, Clark PE, Adam RM, Wu XR, DeGraff DJ (2014) Curr Opin Urol 24: 512-6 Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N (2013) Value Health 16: 610-8 Overview of cancer of the bladder. Hayward SW (1999) Adv Exp Med Biol 462: 395-7 Endourologic management of upper tract transitional cell carcinoma. Clark PE, Streem SB (2004) ScientificWorldJournal 4 Suppl 1: 62-75 Contemporary management of the urethra in patients after radical cystectomy for bladder cancer. Clark PE, Hall MC (2005) Urol Clin North Am 32: 199-206
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.